Company on track for topline data from the 48-week interim analysis of 104 enrolled patients in TransportNPC™ in H1 2025 GAINESVILLE, Fla., February 07, 2025--(BUSINESS WIRE)--Cyclo Therapeutics, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results